Valeant Launches $1B Private Bond To Restructure Debt
Canadian drugmaker Valeant Pharmaceuticals Inc. on Monday launched a $1 billion private bond offering to pay down debt, marking the second time this year that the indebted health care giant has...To view the full article, register now.
Already a subscriber? Click here to view full article